Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2015)

A Case Series of Third-Trimester Raltegravir Initiation: Impact on Maternal HIV-1 Viral Load and Obstetrical Outcomes

  • I Boucoiran,
  • K Tulloch,
  • N Pick,
  • F Kakkar,
  • J van Schalkwyk,
  • D Money,
  • M Boucher

DOI
https://doi.org/10.1155/2015/731043
Journal volume & issue
Vol. 26, no. 3
pp. 145 – 150

Abstract

Read online

OBJECTIVE: To describe the impact of initiating raltegravir (RAL)-containing combination antiretroviral therapy (cART) regimens on HIV viral load (VL) in pregnant women who have high or suboptimal VL suppression late in pregnancy.